At the pathway level, the two groups exhibited distinct functional specialization: the low group showed more active signaling flows related to anti-tumor immunity (such as MHC-I and CD99), whereas the high group demonstrated stronger signaling intensity in pathways promoting cell adhesion and angiogenesis (Figure 3F). This evidence concerns the gene CD99 and neoplasm.